Urology for Practice, 2006, issue 5
Editorial
Člověk míní, pán Bůh mění
Mgr. Marie Beníčková
Urolog. pro Praxi, 2006; 5: 195 
Review articles
POSSIBILITIES OF PREVENTION OF RECURRENT URINARY TRACT INFECTIONS
MUDr. Ivan Kolombo FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
Urolog. pro Praxi, 2006; 5: 204-209
Cystitis is a disease commonly encountered in our urological practice. Ten to twenty percent of women have experience with repeated urinary tract infections (UTI). The causes of the reinfections in women are genetic or acquired factors that increase the risk of colonization of the vagina and thus the risk of the ascendent UTI. In men, reinfections are caused by structural or functional abnormalities of the urinary tract. We always search for possible causes that can change the formation or transport of urine in patients with repeated UTI. Abnormalities should be removed either surgically or pharmacologically. If neglected they fact, it usually leads...
PHARMACOTHERAPY OF BENIGN PROSTATIC HYPERPLASIA, PREVENTION, EFFECTIVE MEDICATIONS, ADVERSE EVENTS
MUDr. Miloš Broďák, MUDr. Lukáš Holub
Urolog. pro Praxi, 2006; 5: 210-213
Benign prostatic hyperplasia is common disease of aging men. The therapy has made great improvements in the last the fifteen years. The most common mode of treatment is pharmacotherapy. The most effective drugs are alpha 1-adrenergic blockers and 5-alpha reductase inhibitors, possibly a combination of these drugs. The authors describe current pharmacotherapy, its efficacy and adverse events.
IS PSA TEST A USEFUL TOOL FOR DETECTING PROSTATE CANCER?
doc. MUDr. Vladimír Študent Ph.D, MUDr. Michal Grepl, MUDr. Milan Král, MUDr. Igor Hartmann
Urolog. pro Praxi, 2006; 5: 214-218
Carcinoma of the prostate (CaP) is a very serious disease in men over the age of 50 years with a high prevalence among men in the Czech Republic. Up to now however no standardized screening has been carried out to this condition. One of the possibilities for detecting early stages of CaP is PSA (prostate specific antigen) examination. It is necessary to use age specific PSA and use the ratio FPSA/PSA, kinetic of PSA, that means PSA-V eventually PSA-DT
THE IMPORTANCE OF PHYTOTHERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
MUDr. Zbyněk Veselský Ph.D
Urolog. pro Praxi, 2006; 5: 220-225
Phytotherapy – treatment with standardized, large-scale produced preparations from herbal drugs – is the oldest type of treatment of benign prostatic hyperplasia (BPH). It is based on experience and knowledge which are sometimes verified empirically rather than being clearly evidenced by aetiopathogenic action. It accounts for some 20 % of the treatment of BPH both in controlled and free market. The most common herbal drug is Serenoa repens (saw palmetto) which is contained in the greatest number of preparations. The second most common is Pygeum africanum (African plum). The other drugs are represented only in small numbers (one worth...
FEMALE URINARY TRACT DISEASE AS SEEN BY A UROGYNAECOLOGIST
MUDr. Jan Miklica
Urolog. pro Praxi, 2006; 5: 226-227
The aetiology of urinary incontinence and lower urinary tract infection is multifactorial; the two conditions often present concurrently with similar manifestations. These include pollakiuria, nocturia, dysuria, and suprapubic pain with urgency and urgent incontinence. According to literary data, urinary incontinence occurs in 20–30 % of women and various forms of urinary infections are represented similarly. Of major significance is appropriate diagnosing and relevant causal treatment. In the case of urinary incontinence, a complex approach and an individual treatment plan according to incontinence type are preferred, in urinary infections,...
At a glance
Farmakologická léčba chronické nenádorové bolesti
MUDr. Marek Hakl Ph.D, MUDr. Radovan Hřib
Urolog. pro Praxi, 2006; 5: 247-249
Case report
Místo bisfosfonátů při skeletovém postižení v uroonkologii
MUDr. Ivan Kolombo FEBU, MUDr. Jitka Kolombová
Urolog. pro Praxi, 2006; 5: 228-242
Zkušenosti s enzymoterapií v rámci komplexní léčby urogenitálních infekcí Chlamydia trachomatis
MUDr. Miroslav Förstl, MUDr. Ivo Kalousek Ph.D, MUDr. Pavel Navrátil CSc, MUDr. Vlasta Štěpánová, MUDr. Miroslav Fajfr
Urolog. pro Praxi, 2006; 5: 243-245
Hemospermie jako první příznak arteriální hypertenze
MUDr. Romana Pavelková, MUDr. Karel Franěk, MUDr. Richard Bokr
Urolog. pro Praxi, 2006; 5: 246
For nurses
Meticilin rezistentní Staphylococcus aureus
Bc. Vladislava Šenkýřová
Urolog. pro Praxi, 2006; 5: 250-252
Information and commentaries
Seminář Neurogenní měchýř - současná diagnostika a léčba
MUDr. Jan Krhut
Urolog. pro Praxi, 2006; 5: 253